Establishing Optimal Quantitative-Polymerase Chain Reaction Assays for Routine Diagnosis and Tracking of Minimal Residual Disease in JAK2-V617F-associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/MPN&MPNr-EuroNet (COST Action BM0902) Study
Leukemia - United Kingdom
doi 10.1038/leu.2013.219
Full Text
Open PDFAbstract
Available in full text
Date
July 17, 2013
Authors
Publisher
Springer Science and Business Media LLC